Claudia Monika Litterst

Title: Claudia Monika Litterst: Innovator in Tumor Disease Research

Introduction

Claudia Monika Litterst is a notable inventor based in Frankfurt, Germany. She has made significant contributions to the field of medical research, particularly in understanding tumor diseases and inflammatory airway diseases. With a total of 2 patents, her work focuses on innovative methods to identify substances that can modulate critical signaling pathways.

Latest Patents

Litterst's latest patents include a test system for measuring the interaction of STAT 6 with NCoA-1. This invention relates to a method for identifying substances that can modulate IL-4 dependent signaling involved in tumor diseases, specifically Hodgkin Lymphomas and asthma. Another significant patent is a method for determining whether a substance can modulate the interaction of STAT6 with NCoA-1, which is crucial for understanding IL-4 signaling.

Career Highlights

Throughout her career, Claudia has worked with prominent companies such as Boehringer Ingelheim International GmbH and Boehringer Ingelheim GmbH. Her experience in these organizations has allowed her to develop and refine her innovative ideas in the medical field.

Collaborations

One of her notable collaborators is Edith Pfitzner, who has worked alongside Litterst in her research endeavors.

Conclusion

Claudia Monika Litterst is a pioneering inventor whose work has the potential to impact the treatment of tumor diseases and inflammatory conditions. Her contributions to medical research are invaluable and continue to inspire future innovations.